Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227524 · ClinicalTrials.gov registry record · NA
Trekking Poles to Aid Multiple Sclerosis Gait Impairment
A NA study, sponsored by Rowan University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02227524: Completed NA study, sponsored by Rowan University.
NCT02227524 is a NA study that has completed, run by Rowan University. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02227524, a NA study, has completed, sponsored by Rowan University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
In this study, the investigators will examine a sample of persons with multiple sclerosis (MS) to determine whether their walking function and ability is different depending on which walking assistive device is used.
Primary Outcome
Temporal and spatial parameters of gait/walking (measured with the GAITRite portable walkway system)
Interventions
- OTHER No device
- DEVICE Single-point cane (SPC)
- DEVICE Four-point cane (FPC)
- DEVICE Trekking pole (TP).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-03-07 |
| Phase | NA |
What the finished NCT02227524 record still lists
NCT02227524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which No device is the first listed.
NCT02227524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02227524 about?
NCT02227524 is a clinical study titled "Trekking Poles to Aid Multiple Sclerosis Gait Impairment". In this study, the investigators will examine a sample of persons with multiple sclerosis (MS) to determine whether their walking function and ability is different depending on which walking assistive device is used.
What is the current status of trial NCT02227524?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-04. Estimated completion is 2019-03-07.
What interventions are being tested in trial NCT02227524?
The interventions under investigation include: No device (OTHER), Single-point cane (SPC) (DEVICE), Four-point cane (FPC) (DEVICE), Trekking pole (TP). (DEVICE).
Who is sponsoring clinical trial NCT02227524?
This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02227524's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia